Uric acid is the end product of purine metabolism and a fairly sensitive readout of how a man's kidneys are handling an insulin resistant metabolism. It is also one of the most over-treated numbers on a standard panel.
Uric acid is the marker most men never look at until something hurts. It sits on the standard metabolic panel next to creatinine, gets a reference range printed beside it, and is then filed away as the gout number. That framing loses most of what it can tell a man in his forties or fifties, because in the great majority of cases an elevated uric acid is not a purine problem at all. It is a kidney handling problem driven by insulin resistance, alcohol intake, body fat and a medication list. This article covers what the thresholds mean, why four randomised trials that lowered urate failed to improve cardiovascular or kidney outcomes, what fructose does that other carbohydrates do not, and where the line sits between a number worth investigating and a number worth medicating.
Uric acid is what a human body produces at the end of purine metabolism. Purines come from two places, roughly a third from food and two thirds from the constant turnover of the body's own cells, and almost every other mammal takes the breakdown one step further by converting uric acid into allantoin using an enzyme called uricase. Humans and the other great apes carry a broken version of that gene, so the chain stops one step early and uric acid circulates at concentrations around ten times higher than in a mouse.
That evolutionary quirk is why uric acid appears on a blood panel at all. It also explains why the number behaves less like a nutrient marker and more like a kidney function marker, because with no enzyme to destroy it the only way a man clears uric acid is to excrete it. Roughly 70 percent leaves through the kidney and the remaining 30 percent through the intestine. When a result comes back high, the question worth asking is almost never what he ate.
6.8 mg/dL
Where Urate Starts To Crystallise
monosodium urate exceeds its solubility in plasma at about this concentration at body temperature
Under 6.0
The Target Once Gout Exists
mg/dL, the treat-to-target threshold in American College of Rheumatology guidance
70 / 30
Kidney Versus Gut Clearance
about 70 percent of urate is excreted renally and 30 percent through the intestine
90%
Of High Results Are Underexcretion
the kidney reabsorbing too much urate, not the body making too much
0
Cardiovascular Events Prevented In ALL-HEART
allopurinol in 5,721 patients with ischaemic heart disease changed nothing
1 in 3
Gout Attacks With A Normal Urate Reading
serum uric acid frequently reads normal or low during an acute flare
What is uric acid and why is it on almost every blood panel?
Uric acid is the final product of purine breakdown, and it is measured because its concentration reflects the balance between purine turnover and renal excretion. It is included on standard chemistry panels largely for historical reasons connected to gout, but the information it carries is broader than that. A uric acid value tracks insulin resistance, alcohol intake, adiposity and kidney function simultaneously, which makes it informative and also makes it non-specific.
The enzyme that converts hypoxanthine into xanthine and then into uric acid is xanthine oxidase, and that enzyme is the target of allopurinol and febuxostat. The kidney side of the equation is handled by a set of transporters in the proximal tubule, chiefly URAT1 and GLUT9, which reabsorb close to 90 percent of the urate that gets filtered. Small differences in how hard those transporters work explain most of the variation between men, which is why hyperuricaemia runs in families and why the strongest genetic associations sit in the transporter genes SLC2A9 and ABCG2 rather than anywhere near purine metabolism.
Input
Purine Turnover
About two thirds of the purine load comes from the body's own cell turnover and only about one third from food, which is why a strict low purine diet moves serum urate by roughly 1 mg/dL at best and why diet alone rarely resolves hyperuricaemia
Step 1
Xanthine Oxidase Does The Conversion
Hypoxanthine becomes xanthine and xanthine becomes uric acid, both reactions catalysed by xanthine oxidase. This single enzyme is what allopurinol and febuxostat inhibit, which is why both drugs lower urate regardless of what the underlying cause was
Shortcut
Fructose Bypasses The Usual Controls
Fructokinase phosphorylates fructose without the feedback braking that governs glucose metabolism, which transiently depletes liver ATP. The resulting AMP is degraded down the purine pathway straight into uric acid, and this is the mechanism that makes fructose distinct from other sugars
Exit 1
The Kidney Reabsorbs Most Of It Back
URAT1 and GLUT9 in the proximal tubule recover close to 90 percent of filtered urate, so net renal excretion is a small fraction of what passes through. Anything that competes for those transporters, including lactate, ketones and thiazide diuretics, raises serum urate
Exit 2
The Gut Handles The Rest
ABCG2 pumps roughly 30 percent of daily urate into the intestine for disposal by gut bacteria. Common loss of function variants in ABCG2 shift the burden onto the kidney and are among the strongest genetic predictors of gout in men
What uric acid level should a man over 40 want?
Below 6.0 mg/dL is a comfortable place for a man to sit, and the reason is physical chemistry rather than epidemiology. Monosodium urate exceeds its solubility in plasma at roughly 6.8 mg/dL at normal body temperature, and cooler peripheral joints reach saturation sooner, which is why the first gout attack so often lands in a big toe. Sustained values above that threshold allow crystal deposits to accumulate silently for years before anything hurts.
Most laboratories print a male reference range of roughly 3.4 to 7.0 mg/dL, and that upper limit is a population statistic rather than a physiological one. Men run about 1 mg/dL higher than premenopausal women because oestrogen promotes urate excretion, and male values step up at puberty and stay there. In SI units, multiply by 59.5 to convert mg/dL to micromoles per litre, so 6.8 mg/dL is about 405 µmol/L. A value under 2.5 mg/dL is unusual and usually points to an SGLT2 inhibitor, a proximal tubule problem or a rare transporter defect rather than to anything a man has done well.
How To Read A Uric Acid Result In A Man
| Result | Classification | What it usually reflects | Reasonable next step |
|---|---|---|---|
| Under 5.0 mg/dL | Comfortably low | Efficient renal urate handling, and in some men an SGLT2 inhibitor, losartan or high dose vitamin C that is lowering it pharmacologically | Nothing, unless the value is under 2.5, which is worth mentioning to a physician |
| 5.0 to 6.8 mg/dL | Within the soluble range | Ordinary variation in a man of this age, sitting below the concentration at which monosodium urate can crystallise | No action, and no benefit demonstrated from pushing it lower in a man who has never had a flare |
| 6.8 to 8.0 mg/dL | Asymptomatic hyperuricaemia | Most often insulin resistance and excess visceral fat, alcohol intake, a thiazide diuretic or low dose aspirin, or early decline in kidney function | Look at HbA1c, triglycerides, eGFR, the medication list and alcohol intake before considering the number itself a target |
| Above 8.0 mg/dL | Marked hyperuricaemia | The same drivers operating together, sometimes with chronic kidney disease, psoriasis, heavy alcohol use or a genetic transporter variant on top | A physician review, since flare risk and stone risk both climb steeply through this range |
| Any value drawn during an acute joint attack | Uninterpretable for diagnosis | Urate frequently falls during a flare because inflammation increases renal excretion, and roughly a third of confirmed gout attacks occur with a normal serum value | Do not rule gout in or out on a level drawn mid attack, and retest two to four weeks after it settles |
What actually raises uric acid in a middle aged man?
In roughly 90 percent of men with a high uric acid the problem is underexcretion by the kidney rather than overproduction, and the single most common driver is insulin resistance. Insulin acts on the proximal tubule to increase sodium reabsorption, and urate reabsorption rides along with it, so a hyperinsulinaemic man retains more urate at every level of purine intake. This is why uric acid tracks so closely with waist circumference, triglycerides and fatty liver, and why it is better understood as a metabolic marker than a dietary one.
Alcohol is the second reliable contributor, and the type matters. Beer carries a substantial purine load from guanosine in brewer's yeast on top of the ethanol effect, spirits raise urate through ethanol metabolism and lactate competition alone, and moderate wine intake has repeatedly shown little association with gout risk in cohort studies. Medications account for another large share. Thiazide and loop diuretics raise urate directly by increasing tubular reabsorption, low dose aspirin does the same at cardioprotective doses, and ciclosporin is a potent offender in transplant patients.
These proportions summarise the causes clinicians commonly encounter rather than measured shares from a single cohort, and they overlap heavily in practice. A 52 year old man on a thiazide for blood pressure, carrying 15 kg he did not have at 35 and drinking four beers on a Friday, has three of these operating at once and no way to attribute his 8.1 mg/dL to any one of them. The useful reading is that the top three slices are all modifiable and none of them is purine intake.
Does lowering uric acid prevent heart attacks or protect the kidneys?
On the randomised evidence available, no. Uric acid is strongly associated with hypertension, chronic kidney disease and cardiovascular events in observational data, and the trials built to test whether lowering it changes those outcomes have come back negative with unusual consistency. ALL-HEART randomised 5,721 patients over 60 with ischaemic heart disease to allopurinol or usual care, followed them for a median of nearly five years, and found no reduction in cardiovascular death, myocardial infarction or stroke.
The kidney trials tell the same story. CKD-FIX gave allopurinol to 369 patients with chronic kidney disease at risk of progression and found no slowing of eGFR decline. PERL tested allopurinol in 530 patients with type 1 diabetes and early kidney disease and also found no benefit, with a slightly lower GFR in the treated group at the end. On the safety side, CARES reported higher cardiovascular and all-cause mortality with febuxostat than allopurinol in gout patients with cardiovascular disease, which produced an FDA boxed warning in 2019, while the larger FAST trial published in 2020 did not reproduce that mortality signal. Both the American College of Physicians and the American College of Rheumatology advise against drug treatment of asymptomatic hyperuricaemia, and these trials are why.
Does fructose really matter, and does a low purine diet work?
Fructose is the one dietary component with a mechanism distinct from everything else on the plate, and sugar sweetened drinks are the form that matters most. Fructokinase phosphorylates fructose without the feedback control that regulates glucose handling, transiently depleting ATP in the liver and generating AMP that degrades directly into uric acid. Prospective cohort data from the Health Professionals Follow-up Study found men drinking two or more sugar sweetened soft drinks daily had substantially higher gout incidence than men drinking less than one a month, and fruit juice showed a similar direction.
A conventional low purine diet performs poorly by comparison, and the reason is arithmetic. Only about a third of the purine load is dietary, so even aggressive restriction moves serum urate by around 1 mg/dL, which is rarely enough to bring an 8.5 down under the crystallisation threshold. Choi and colleagues, analysing more than 47,000 men in the same cohort, found that red meat and seafood raised gout risk while purine-rich vegetables such as spinach, peas and lentils did not, and that dairy intake was protective. The DASH pattern lowers urate by roughly 0.35 mg/dL on average and considerably more in men who start above 7.0, which is a better return than purine counting for less effort.
This curve illustrates the shape of the response rather than measured data from one trial, and the bump at week two is the part worth understanding. Rapid weight loss, prolonged fasting and ketogenic transitions all raise urate temporarily because ketone bodies compete with urate for the URAT1 transporter in the kidney, which is why gout flares cluster in the first few weeks of an aggressive diet. That effect resolves as weight loss continues, and the longer trajectory is downward. A man with known gout who is starting a steep deficit should expect this and should raise it with his physician rather than abandoning the diet at week three.
Do GLP-1 medications, diuretics or testosterone change uric acid?
GLP-1 receptor agonists lower uric acid modestly, and the effect appears to run mostly through weight loss and improved insulin sensitivity rather than a direct action on the kidney. Observational cohort analyses comparing GLP-1 agonists with other glucose lowering drugs have reported lower rates of gout flares, which is consistent with the mechanism but is not the same as trial evidence. SGLT2 inhibitors are the more interesting case, since they lower serum urate by roughly 0.6 to 0.8 mg/dL through a direct mechanism, with urinary glucose driving urate excretion via GLUT9 in the tubule.
Diuretics work in the opposite direction, and this is the most common iatrogenic cause of hyperuricaemia in men over 50. Thiazides and loop diuretics both raise urate meaningfully, while losartan is uniquely uricosuric among the angiotensin receptor blockers and lowers it by roughly 0.2 to 0.4 mg/dL, which makes it a relevant option when a man needs blood pressure control and has gout. On testosterone, the evidence is thin and mostly indirect. Male urate rises at puberty and stays roughly 1 mg/dL above female values because oestrogen is uricosuric, and cross-sectional studies of testosterone therapy have reported small increases in urate that are hard to separate from changes in haematocrit, muscle mass and hydration. No trial supports adjusting testosterone therapy on the basis of a uric acid result, and testosterone remains a prescription treatment whose management belongs with a clinician.
How should the test be drawn and interpreted?
Draw uric acid fasting in the morning, with no alcohol and no unusually heavy meat or seafood meal in the preceding 24 hours, and note the medication list on the same page as the result. Uric acid is chemically stable in the tube, so it does not carry the sample handling problems that plague markers like homocysteine, but it is sensitive to hydration state and to what a man did the day before. Hard eccentric training, a sauna session and a night of poor fluid intake can each add a few tenths of a point.
Read it as a metabolic marker first
A uric acid above 6.8 in a man with no gout history is a prompt to look at HbA1c, fasting insulin, triglycerides, liver enzymes and waist circumference. Insulin resistance is the most common explanation and the one with the largest downstream consequences beyond the joints
Audit the medication list before blaming the diet
Thiazide diuretics, loop diuretics and low dose aspirin all raise urate through renal transport effects. None should be stopped over a blood marker, and knowing one of them is in play prevents a man from spending six months eliminating shellfish for nothing
Check kidney function
Reduced eGFR raises urate reliably because the kidney does most of the clearing. An unexplained elevation in a man over 50 is worth pairing with eGFR and a urine albumin to creatinine ratio, since the kidney finding matters more than the urate finding
Treat gout, not a number
Both the American College of Physicians and the American College of Rheumatology advise against urate lowering drugs for asymptomatic hyperuricaemia. Once a man has had a flare, a tophus or a urate stone, the situation reverses and sustained treatment to below 6.0 mg/dL is well supported
Do not diagnose or exclude gout on the level alone
Roughly a third of acute attacks occur with a serum urate inside the reference range because inflammation increases renal excretion during the flare. Joint aspiration showing monosodium urate crystals remains the definitive test, and a normal level mid attack proves nothing
Expect a temporary rise when a diet starts
Ketones compete with urate for the URAT1 transporter, so aggressive calorie restriction, fasting protocols and ketogenic transitions push urate up for the first few weeks before the weight loss pushes it down. A man with gout should plan for that window rather than be surprised by it
Week 1: Establish what the number actually is
Weeks 2 to 6: Address the drivers that are actually large
Weeks 6 to 24: Work on the metabolic cause
Month 6 onward: Retest and decide
So is uric acid worth tracking?
Uric acid is worth reading every time it appears on a panel, which for most men is once a year already. Its value is as a cheap, early and fairly sensitive readout of insulin resistance and renal urate handling, two things that rarely announce themselves. A man in his forties whose uric acid has drifted from 5.6 to 7.4 across four annual panels is being told something about his metabolism, and the joints are the least of it.
What uric acid is not is a target to medicate in the absence of crystal disease. ALL-HEART, CKD-FIX and PERL between them randomised more than 6,600 people, lowered urate successfully, and improved nothing. That result is worth holding onto because the observational association is genuinely strong and the mechanistic story is genuinely appealing, and neither of those things turned out to be enough. In a man who has had a gout flare, a tophus or a urate stone, the calculation flips completely and sustained treatment below 6.0 mg/dL is one of the better supported interventions in rheumatology.
Medical Disclaimer
This article is for educational purposes only and is not medical advice. Nothing here diagnoses, treats, cures or prevents any disease or condition, including gout, kidney stones, chronic kidney disease, cardiovascular disease, diabetes or hypogonadism. Allopurinol, febuxostat, thiazide and loop diuretics, losartan, SGLT2 inhibitors, GLP-1 receptor agonists and testosterone are prescription products discussed here only in terms of what published research has measured, and no one should start, stop or adjust a prescribed medication on the basis of a blood marker. Acute joint pain, suspected gout and urate kidney stones require evaluation by a physician. The charts in this article are illustrative representations of direction and relative magnitude rather than measured trial results, and the studies referenced differ in population, intervention, duration and endpoint, so their figures are not directly comparable to one another.
Continue Reading
Insulin Resistance and Testosterone: The Fasting Number Men Forget to Order
12 min read
hs-CRP in Men Over 40: The Inflammation Marker Most Blood Panels Leave Off
11 min read
Berberine vs Metformin for Men Over 40: What the Head to Head Data Actually Shows
13 min read